ArticleJournal of clinical medicine2023

Risk of Hemolytic Anemia in IBD Patients with Glucose-6-Phosphate Dehydrogenase Deficiency Treated with Mesalamine: Results of a Retrospective-Prospective and Ex Vivo Study.

Maria Pina Dore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.